(Q36310909)

13 August 2017

1 reference

title

The epidemiology and control of anaemia among pre-ESRD patients with chronic kidney disease (English)

1 reference

13 August 2017

1

McClellan WM

1 reference

13 August 2017

Jurkovitz C

2

1 reference

13 August 2017

Abramson J

series ordinal

3

1 reference

13 August 2017

publication date

1 December 2005

1 reference

European Journal of Clinical Investigation

13 August 2017

published in

1 reference

13 August 2017

volume

35 Suppl 3

1 reference

13 August 2017

page(s)

58-65

1 reference

Isolation and characterization of genomic and cDNA clones of human erythropoietin

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Trends in anemia management among US hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Trends in anemia at initiation of dialysis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

An estimate of the size of the US predialysis population with renal insufficiency and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Relationship between hematocrit and renal function in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Iron status and hemoglobin level in chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

PRE-dialysis survey on anaemia management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Influence of target hemoglobin in dialysis patients on morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Contribution of anaemia to progression of renal disease: a debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Physiological role of CLC-K1 chloride channel in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2005.01532.X

Erythropoietin: structure, control of production, and function

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Use of erythropoietin before the initiation of dialysis and its impact on mortality

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Anaemia in end-stage renal disease: pathophysiological considerations

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Normalizing hematocrit in dialysis patients improves brain function

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Treatment of the anemia of progressive renal failure with recombinant human erythropoietin

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Radioimmunoassay of erythropoietin in chronic uraemia or anephric patients

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Identification of the renal erythropoietin-producing cells using transgenic mice

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Anemia: an early complication of chronic renal insufficiency

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Cloning and expression of the human erythropoietin gene

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Iron and zinc status of patients with chronic renal failure who are not on dialysis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Why is erythropoietin made in the kidney? The kidney functions as a critmeter

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1365-2362.2005.01532.X

Identifiers

DOI

10.1111/J.1365-2362.2005.01532.X

1 reference

13 August 2017

1 reference